chloroquine has been researched along with Genetic Diseases in 1 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " One of the difficulties in this setup is the poor bioavailability of oligonucleotides, as the most frequently used transfection agents are unsuitable for in vivo use." | 1.33 | Induction of splice correction by cell-penetrating peptide nucleic acids. ( El-Andaloussi, S; Johansson, HJ; Langel, U; Lundberg, P, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Andaloussi, S | 1 |
| Johansson, HJ | 1 |
| Lundberg, P | 1 |
| Langel, U | 1 |
1 other study available for chloroquine and Genetic Diseases
| Article | Year |
|---|---|
Induction of splice correction by cell-penetrating peptide nucleic acids.
Topics: Cell Membrane Permeability; Chloroquine; Endocytosis; Gene Transfer Techniques; Genetic Diseases, In | 2006 |